Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Molecular Structure|June 21, 2021
COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, et al.
Scientific Reports|January 21, 2025
Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulationsIsmail Hdoufane, Mehdi Oubahmane, Youssef Habibi, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics SimulationsMehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, et al.
Journal of Biomolecular Structure & Dynamics|October 29, 2020
In silico design and analysis of NS4B inhibitors against hepatitis C virusIsmail Hdoufane, Imane Bjij, Mehdi Oubahmane, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Monte Carlo Method and GA-MLR-Based QSAR Modeling of NS5A Inhibitors against the Hepatitis C VirusWissal Liman, Mehdi Oubahmane, Ismail Hdoufane, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and ApplicationsWissal Liman, Nouhaila Ait Lahcen, Mehdi Oubahmane, et al.
Scientific Reports|December 31, 2024
Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virusWissal Liman, Mehdi Oubahmane, Nouhaila Ait Lahcen, et al.
Natural Product Research|March 23, 2024
Molecular docking of quercetin: a promising approach for the development of new anti-inflammatory and analgesic drugsAmina Ettitaou, Hamid Kabdy, Khadija Oubella, et al.
Current Topics in Medicinal Chemistry|July 27, 2022
Host Cell Proteases Mediating SARS-CoV-2 Entry: An OverviewMehdi Oubahmane, Ismail Hdoufane, Imane Bjij, et al.
Pageof 2